Medical Care
Global Gene Editing Therapy Market Research Report 2026
- May 01, 26
- ID: 760545
- Pages: 107
- Figures: 104
- Views: 19
This report delivers a comprehensive overview of the global Gene Editing Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gene Editing Therapy. The Gene Editing Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Gene Editing Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Gene Editing Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
CRISPR Therapeutics
Beam Therapeutics
Editas Medicine
Verve Therapeutics
Bluebird Bio
Intellia Therapeutics
Vertex Pharmaceuticals
Caribou Biosciences
Segment by Type
In Vivo Gene Editing
In Vitro Gene Editing
Segment by Application
Thalassemia
Cancer
Cystic Fibrosis
Muscular Dystrophy
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Gene Editing Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Gene Editing Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Gene Editing Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
CRISPR Therapeutics
Beam Therapeutics
Editas Medicine
Verve Therapeutics
Bluebird Bio
Intellia Therapeutics
Vertex Pharmaceuticals
Caribou Biosciences
Segment by Type
In Vivo Gene Editing
In Vitro Gene Editing
Segment by Application
Thalassemia
Cancer
Cystic Fibrosis
Muscular Dystrophy
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Gene Editing Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Editing Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 In Vivo Gene Editing
1.2.3 In Vitro Gene Editing
1.3 Market by Application
1.3.1 Global Gene Editing Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Thalassemia
1.3.3 Cancer
1.3.4 Cystic Fibrosis
1.3.5 Muscular Dystrophy
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Editing Therapy Market Perspective (2021–2032)
2.2 Global Gene Editing Therapy Growth Trends by Region
2.2.1 Global Gene Editing Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Gene Editing Therapy Historic Market Size by Region (2021–2026)
2.2.3 Gene Editing Therapy Forecasted Market Size by Region (2027–2032)
2.3 Gene Editing Therapy Market Dynamics
2.3.1 Gene Editing Therapy Industry Trends
2.3.2 Gene Editing Therapy Market Drivers
2.3.3 Gene Editing Therapy Market Challenges
2.3.4 Gene Editing Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Editing Therapy Players by Revenue
3.1.1 Global Top Gene Editing Therapy Players by Revenue (2021–2026)
3.1.2 Global Gene Editing Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Gene Editing Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Gene Editing Therapy Revenue
3.4 Global Gene Editing Therapy Market Concentration Ratio
3.4.1 Global Gene Editing Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Editing Therapy Revenue in 2025
3.5 Global Key Players of Gene Editing Therapy Head Offices and Areas Served
3.6 Global Key Players of Gene Editing Therapy, Products and Applications
3.7 Global Key Players of Gene Editing Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Gene Editing Therapy Breakdown Data by Type
4.1 Global Gene Editing Therapy Historic Market Size by Type (2021–2026)
4.2 Global Gene Editing Therapy Forecasted Market Size by Type (2027–2032)
5 Gene Editing Therapy Breakdown Data by Application
5.1 Global Gene Editing Therapy Historic Market Size by Application (2021–2026)
5.2 Global Gene Editing Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Gene Editing Therapy Market Size (2021–2032)
6.2 North America Gene Editing Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Gene Editing Therapy Market Size by Country (2021–2026)
6.4 North America Gene Editing Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Editing Therapy Market Size (2021–2032)
7.2 Europe Gene Editing Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Gene Editing Therapy Market Size by Country (2021–2026)
7.4 Europe Gene Editing Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Gene Editing Therapy Market Size (2021–2032)
8.2 Asia-Pacific Gene Editing Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Gene Editing Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Gene Editing Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Gene Editing Therapy Market Size (2021–2032)
9.2 Latin America Gene Editing Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Gene Editing Therapy Market Size by Country (2021–2026)
9.4 Latin America Gene Editing Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Editing Therapy Market Size (2021–2032)
10.2 Middle East & Africa Gene Editing Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Gene Editing Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Gene Editing Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CRISPR Therapeutics
11.1.1 CRISPR Therapeutics Company Details
11.1.2 CRISPR Therapeutics Business Overview
11.1.3 CRISPR Therapeutics Gene Editing Therapy Introduction
11.1.4 CRISPR Therapeutics Revenue in Gene Editing Therapy Business (2021–2026)
11.1.5 CRISPR Therapeutics Recent Development
11.2 Beam Therapeutics
11.2.1 Beam Therapeutics Company Details
11.2.2 Beam Therapeutics Business Overview
11.2.3 Beam Therapeutics Gene Editing Therapy Introduction
11.2.4 Beam Therapeutics Revenue in Gene Editing Therapy Business (2021–2026)
11.2.5 Beam Therapeutics Recent Development
11.3 Editas Medicine
11.3.1 Editas Medicine Company Details
11.3.2 Editas Medicine Business Overview
11.3.3 Editas Medicine Gene Editing Therapy Introduction
11.3.4 Editas Medicine Revenue in Gene Editing Therapy Business (2021–2026)
11.3.5 Editas Medicine Recent Development
11.4 Verve Therapeutics
11.4.1 Verve Therapeutics Company Details
11.4.2 Verve Therapeutics Business Overview
11.4.3 Verve Therapeutics Gene Editing Therapy Introduction
11.4.4 Verve Therapeutics Revenue in Gene Editing Therapy Business (2021–2026)
11.4.5 Verve Therapeutics Recent Development
11.5 Bluebird Bio
11.5.1 Bluebird Bio Company Details
11.5.2 Bluebird Bio Business Overview
11.5.3 Bluebird Bio Gene Editing Therapy Introduction
11.5.4 Bluebird Bio Revenue in Gene Editing Therapy Business (2021–2026)
11.5.5 Bluebird Bio Recent Development
11.6 Intellia Therapeutics
11.6.1 Intellia Therapeutics Company Details
11.6.2 Intellia Therapeutics Business Overview
11.6.3 Intellia Therapeutics Gene Editing Therapy Introduction
11.6.4 Intellia Therapeutics Revenue in Gene Editing Therapy Business (2021–2026)
11.6.5 Intellia Therapeutics Recent Development
11.7 Vertex Pharmaceuticals
11.7.1 Vertex Pharmaceuticals Company Details
11.7.2 Vertex Pharmaceuticals Business Overview
11.7.3 Vertex Pharmaceuticals Gene Editing Therapy Introduction
11.7.4 Vertex Pharmaceuticals Revenue in Gene Editing Therapy Business (2021–2026)
11.7.5 Vertex Pharmaceuticals Recent Development
11.8 Caribou Biosciences
11.8.1 Caribou Biosciences Company Details
11.8.2 Caribou Biosciences Business Overview
11.8.3 Caribou Biosciences Gene Editing Therapy Introduction
11.8.4 Caribou Biosciences Revenue in Gene Editing Therapy Business (2021–2026)
11.8.5 Caribou Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Editing Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 In Vivo Gene Editing
1.2.3 In Vitro Gene Editing
1.3 Market by Application
1.3.1 Global Gene Editing Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Thalassemia
1.3.3 Cancer
1.3.4 Cystic Fibrosis
1.3.5 Muscular Dystrophy
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Editing Therapy Market Perspective (2021–2032)
2.2 Global Gene Editing Therapy Growth Trends by Region
2.2.1 Global Gene Editing Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Gene Editing Therapy Historic Market Size by Region (2021–2026)
2.2.3 Gene Editing Therapy Forecasted Market Size by Region (2027–2032)
2.3 Gene Editing Therapy Market Dynamics
2.3.1 Gene Editing Therapy Industry Trends
2.3.2 Gene Editing Therapy Market Drivers
2.3.3 Gene Editing Therapy Market Challenges
2.3.4 Gene Editing Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Editing Therapy Players by Revenue
3.1.1 Global Top Gene Editing Therapy Players by Revenue (2021–2026)
3.1.2 Global Gene Editing Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Gene Editing Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Gene Editing Therapy Revenue
3.4 Global Gene Editing Therapy Market Concentration Ratio
3.4.1 Global Gene Editing Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Editing Therapy Revenue in 2025
3.5 Global Key Players of Gene Editing Therapy Head Offices and Areas Served
3.6 Global Key Players of Gene Editing Therapy, Products and Applications
3.7 Global Key Players of Gene Editing Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Gene Editing Therapy Breakdown Data by Type
4.1 Global Gene Editing Therapy Historic Market Size by Type (2021–2026)
4.2 Global Gene Editing Therapy Forecasted Market Size by Type (2027–2032)
5 Gene Editing Therapy Breakdown Data by Application
5.1 Global Gene Editing Therapy Historic Market Size by Application (2021–2026)
5.2 Global Gene Editing Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Gene Editing Therapy Market Size (2021–2032)
6.2 North America Gene Editing Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Gene Editing Therapy Market Size by Country (2021–2026)
6.4 North America Gene Editing Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Editing Therapy Market Size (2021–2032)
7.2 Europe Gene Editing Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Gene Editing Therapy Market Size by Country (2021–2026)
7.4 Europe Gene Editing Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Gene Editing Therapy Market Size (2021–2032)
8.2 Asia-Pacific Gene Editing Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Gene Editing Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Gene Editing Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Gene Editing Therapy Market Size (2021–2032)
9.2 Latin America Gene Editing Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Gene Editing Therapy Market Size by Country (2021–2026)
9.4 Latin America Gene Editing Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Editing Therapy Market Size (2021–2032)
10.2 Middle East & Africa Gene Editing Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Gene Editing Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Gene Editing Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CRISPR Therapeutics
11.1.1 CRISPR Therapeutics Company Details
11.1.2 CRISPR Therapeutics Business Overview
11.1.3 CRISPR Therapeutics Gene Editing Therapy Introduction
11.1.4 CRISPR Therapeutics Revenue in Gene Editing Therapy Business (2021–2026)
11.1.5 CRISPR Therapeutics Recent Development
11.2 Beam Therapeutics
11.2.1 Beam Therapeutics Company Details
11.2.2 Beam Therapeutics Business Overview
11.2.3 Beam Therapeutics Gene Editing Therapy Introduction
11.2.4 Beam Therapeutics Revenue in Gene Editing Therapy Business (2021–2026)
11.2.5 Beam Therapeutics Recent Development
11.3 Editas Medicine
11.3.1 Editas Medicine Company Details
11.3.2 Editas Medicine Business Overview
11.3.3 Editas Medicine Gene Editing Therapy Introduction
11.3.4 Editas Medicine Revenue in Gene Editing Therapy Business (2021–2026)
11.3.5 Editas Medicine Recent Development
11.4 Verve Therapeutics
11.4.1 Verve Therapeutics Company Details
11.4.2 Verve Therapeutics Business Overview
11.4.3 Verve Therapeutics Gene Editing Therapy Introduction
11.4.4 Verve Therapeutics Revenue in Gene Editing Therapy Business (2021–2026)
11.4.5 Verve Therapeutics Recent Development
11.5 Bluebird Bio
11.5.1 Bluebird Bio Company Details
11.5.2 Bluebird Bio Business Overview
11.5.3 Bluebird Bio Gene Editing Therapy Introduction
11.5.4 Bluebird Bio Revenue in Gene Editing Therapy Business (2021–2026)
11.5.5 Bluebird Bio Recent Development
11.6 Intellia Therapeutics
11.6.1 Intellia Therapeutics Company Details
11.6.2 Intellia Therapeutics Business Overview
11.6.3 Intellia Therapeutics Gene Editing Therapy Introduction
11.6.4 Intellia Therapeutics Revenue in Gene Editing Therapy Business (2021–2026)
11.6.5 Intellia Therapeutics Recent Development
11.7 Vertex Pharmaceuticals
11.7.1 Vertex Pharmaceuticals Company Details
11.7.2 Vertex Pharmaceuticals Business Overview
11.7.3 Vertex Pharmaceuticals Gene Editing Therapy Introduction
11.7.4 Vertex Pharmaceuticals Revenue in Gene Editing Therapy Business (2021–2026)
11.7.5 Vertex Pharmaceuticals Recent Development
11.8 Caribou Biosciences
11.8.1 Caribou Biosciences Company Details
11.8.2 Caribou Biosciences Business Overview
11.8.3 Caribou Biosciences Gene Editing Therapy Introduction
11.8.4 Caribou Biosciences Revenue in Gene Editing Therapy Business (2021–2026)
11.8.5 Caribou Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gene Editing Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of In Vivo Gene Editing
Table 3. Key Players of In Vitro Gene Editing
Table 4. Global Gene Editing Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Gene Editing Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Gene Editing Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global Gene Editing Therapy Market Share by Region (2021–2026)
Table 8. Global Gene Editing Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Gene Editing Therapy Market Share by Region (2027–2032)
Table 10. Gene Editing Therapy Market Trends
Table 11. Gene Editing Therapy Market Drivers
Table 12. Gene Editing Therapy Market Challenges
Table 13. Gene Editing Therapy Market Restraints
Table 14. Global Gene Editing Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global Gene Editing Therapy Market Share by Players (2021–2026)
Table 16. Global Top Gene Editing Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Gene Editing Therapy Revenue, 2025
Table 17. Ranking of Global Top Gene Editing Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Gene Editing Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Gene Editing Therapy, Headquarters and Area Served
Table 20. Global Key Players of Gene Editing Therapy, Products and Applications
Table 21. Global Key Players of Gene Editing Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Gene Editing Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global Gene Editing Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global Gene Editing Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Gene Editing Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global Gene Editing Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global Gene Editing Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global Gene Editing Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Gene Editing Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Gene Editing Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America Gene Editing Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Gene Editing Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Gene Editing Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Gene Editing Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Gene Editing Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Gene Editing Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Gene Editing Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Gene Editing Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Gene Editing Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Gene Editing Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. CRISPR Therapeutics Company Details
Table 47. CRISPR Therapeutics Business Overview
Table 48. CRISPR Therapeutics Gene Editing Therapy Product
Table 49. CRISPR Therapeutics Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 50. CRISPR Therapeutics Recent Development
Table 51. Beam Therapeutics Company Details
Table 52. Beam Therapeutics Business Overview
Table 53. Beam Therapeutics Gene Editing Therapy Product
Table 54. Beam Therapeutics Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 55. Beam Therapeutics Recent Development
Table 56. Editas Medicine Company Details
Table 57. Editas Medicine Business Overview
Table 58. Editas Medicine Gene Editing Therapy Product
Table 59. Editas Medicine Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 60. Editas Medicine Recent Development
Table 61. Verve Therapeutics Company Details
Table 62. Verve Therapeutics Business Overview
Table 63. Verve Therapeutics Gene Editing Therapy Product
Table 64. Verve Therapeutics Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 65. Verve Therapeutics Recent Development
Table 66. Bluebird Bio Company Details
Table 67. Bluebird Bio Business Overview
Table 68. Bluebird Bio Gene Editing Therapy Product
Table 69. Bluebird Bio Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 70. Bluebird Bio Recent Development
Table 71. Intellia Therapeutics Company Details
Table 72. Intellia Therapeutics Business Overview
Table 73. Intellia Therapeutics Gene Editing Therapy Product
Table 74. Intellia Therapeutics Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 75. Intellia Therapeutics Recent Development
Table 76. Vertex Pharmaceuticals Company Details
Table 77. Vertex Pharmaceuticals Business Overview
Table 78. Vertex Pharmaceuticals Gene Editing Therapy Product
Table 79. Vertex Pharmaceuticals Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 80. Vertex Pharmaceuticals Recent Development
Table 81. Caribou Biosciences Company Details
Table 82. Caribou Biosciences Business Overview
Table 83. Caribou Biosciences Gene Editing Therapy Product
Table 84. Caribou Biosciences Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 85. Caribou Biosciences Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. Gene Editing Therapy Picture
Figure 2. Global Gene Editing Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Gene Editing Therapy Market Share by Type: 2025 vs 2032
Figure 4. In Vivo Gene Editing Features
Figure 5. In Vitro Gene Editing Features
Figure 6. Global Gene Editing Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Gene Editing Therapy Market Share by Application: 2025 vs 2032
Figure 8. Thalassemia Case Studies
Figure 9. Cancer Case Studies
Figure 10. Cystic Fibrosis Case Studies
Figure 11. Muscular Dystrophy Case Studies
Figure 12. Others Case Studies
Figure 13. Gene Editing Therapy Report Years Considered
Figure 14. Global Gene Editing Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Gene Editing Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Gene Editing Therapy Market Share by Region: 2025 vs 2032
Figure 17. Global Gene Editing Therapy Market Share by Players in 2025
Figure 18. Global Gene Editing Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Gene Editing Therapy Revenue in 2025
Figure 20. North America Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Gene Editing Therapy Market Share by Country (2021–2032)
Figure 22. United States Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Gene Editing Therapy Market Share by Country (2021–2032)
Figure 26. Germany Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Gene Editing Therapy Market Share by Region (2021–2032)
Figure 34. China Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Gene Editing Therapy Market Share by Country (2021–2032)
Figure 42. Mexico Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Gene Editing Therapy Market Share by Country (2021–2032)
Figure 46. Israel Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. CRISPR Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 50. Beam Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 51. Editas Medicine Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 52. Verve Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 53. Bluebird Bio Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 54. Intellia Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 55. Vertex Pharmaceuticals Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 56. Caribou Biosciences Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Gene Editing Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of In Vivo Gene Editing
Table 3. Key Players of In Vitro Gene Editing
Table 4. Global Gene Editing Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Gene Editing Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Gene Editing Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global Gene Editing Therapy Market Share by Region (2021–2026)
Table 8. Global Gene Editing Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Gene Editing Therapy Market Share by Region (2027–2032)
Table 10. Gene Editing Therapy Market Trends
Table 11. Gene Editing Therapy Market Drivers
Table 12. Gene Editing Therapy Market Challenges
Table 13. Gene Editing Therapy Market Restraints
Table 14. Global Gene Editing Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global Gene Editing Therapy Market Share by Players (2021–2026)
Table 16. Global Top Gene Editing Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Gene Editing Therapy Revenue, 2025
Table 17. Ranking of Global Top Gene Editing Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Gene Editing Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Gene Editing Therapy, Headquarters and Area Served
Table 20. Global Key Players of Gene Editing Therapy, Products and Applications
Table 21. Global Key Players of Gene Editing Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Gene Editing Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global Gene Editing Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global Gene Editing Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Gene Editing Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global Gene Editing Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global Gene Editing Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global Gene Editing Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Gene Editing Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Gene Editing Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America Gene Editing Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Gene Editing Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Gene Editing Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Gene Editing Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Gene Editing Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Gene Editing Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Gene Editing Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Gene Editing Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Gene Editing Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Gene Editing Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. CRISPR Therapeutics Company Details
Table 47. CRISPR Therapeutics Business Overview
Table 48. CRISPR Therapeutics Gene Editing Therapy Product
Table 49. CRISPR Therapeutics Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 50. CRISPR Therapeutics Recent Development
Table 51. Beam Therapeutics Company Details
Table 52. Beam Therapeutics Business Overview
Table 53. Beam Therapeutics Gene Editing Therapy Product
Table 54. Beam Therapeutics Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 55. Beam Therapeutics Recent Development
Table 56. Editas Medicine Company Details
Table 57. Editas Medicine Business Overview
Table 58. Editas Medicine Gene Editing Therapy Product
Table 59. Editas Medicine Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 60. Editas Medicine Recent Development
Table 61. Verve Therapeutics Company Details
Table 62. Verve Therapeutics Business Overview
Table 63. Verve Therapeutics Gene Editing Therapy Product
Table 64. Verve Therapeutics Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 65. Verve Therapeutics Recent Development
Table 66. Bluebird Bio Company Details
Table 67. Bluebird Bio Business Overview
Table 68. Bluebird Bio Gene Editing Therapy Product
Table 69. Bluebird Bio Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 70. Bluebird Bio Recent Development
Table 71. Intellia Therapeutics Company Details
Table 72. Intellia Therapeutics Business Overview
Table 73. Intellia Therapeutics Gene Editing Therapy Product
Table 74. Intellia Therapeutics Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 75. Intellia Therapeutics Recent Development
Table 76. Vertex Pharmaceuticals Company Details
Table 77. Vertex Pharmaceuticals Business Overview
Table 78. Vertex Pharmaceuticals Gene Editing Therapy Product
Table 79. Vertex Pharmaceuticals Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 80. Vertex Pharmaceuticals Recent Development
Table 81. Caribou Biosciences Company Details
Table 82. Caribou Biosciences Business Overview
Table 83. Caribou Biosciences Gene Editing Therapy Product
Table 84. Caribou Biosciences Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
Table 85. Caribou Biosciences Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. Gene Editing Therapy Picture
Figure 2. Global Gene Editing Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Gene Editing Therapy Market Share by Type: 2025 vs 2032
Figure 4. In Vivo Gene Editing Features
Figure 5. In Vitro Gene Editing Features
Figure 6. Global Gene Editing Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Gene Editing Therapy Market Share by Application: 2025 vs 2032
Figure 8. Thalassemia Case Studies
Figure 9. Cancer Case Studies
Figure 10. Cystic Fibrosis Case Studies
Figure 11. Muscular Dystrophy Case Studies
Figure 12. Others Case Studies
Figure 13. Gene Editing Therapy Report Years Considered
Figure 14. Global Gene Editing Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Gene Editing Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Gene Editing Therapy Market Share by Region: 2025 vs 2032
Figure 17. Global Gene Editing Therapy Market Share by Players in 2025
Figure 18. Global Gene Editing Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Gene Editing Therapy Revenue in 2025
Figure 20. North America Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Gene Editing Therapy Market Share by Country (2021–2032)
Figure 22. United States Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Gene Editing Therapy Market Share by Country (2021–2032)
Figure 26. Germany Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Gene Editing Therapy Market Share by Region (2021–2032)
Figure 34. China Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Gene Editing Therapy Market Share by Country (2021–2032)
Figure 42. Mexico Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Gene Editing Therapy Market Share by Country (2021–2032)
Figure 46. Israel Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. CRISPR Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 50. Beam Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 51. Editas Medicine Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 52. Verve Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 53. Bluebird Bio Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 54. Intellia Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 55. Vertex Pharmaceuticals Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 56. Caribou Biosciences Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232